Patent classifications
C02F3/34
Nitrite-oxidizing bacteria activity inhibitor and method
A device and method for shortcut nitrogen removal and nitrite-oxidizing bacteria activity inhibition are disclosed herein. An embodiment of the present invention provides a hollow fiber diffuser comprising: a plurality of hollow fibers on which bacteria can be attached and grow; and an inlet capable of supplying gas to one sides of the plurality of hollow fibers, wherein the gas includes oxygen and carbon dioxide, nitrite can be produced by the oxygen, and the concentration of oxygen in the gas is adjusted by the oxygen and the carbon dioxide.
HYBRID ACTIVATED IRON-BIOLOGICAL WATER TREATMENT SYSTEM AND METHOD
A hybrid activated iron-biological treatment system and method for treating wastewater. The treatment system includes a combination of zero valent iron, ferrous iron, an iron oxide, and a denitrification microorganism.
METHOD FOR TREATING WASTEWATER, AND ACTIVATOR FOR TREATING WASTEWATER
A method for treating wastewater and an activator for treating wastewater that maximizes the utilization of microorganisms such as Bacillus bacteria in an activated sludge treatment of wastewater while minimizing treatment cost. In the method for treating wastewater, wastewater including organic matter is introduced into a treatment tank and the wastewater is subjected to an activated sludge treatment by microorganisms in the treatment tank, wherein an activator containing a component for activating the microorganisms is added to the wastewater to be subjected to the activated sludge treatment in the treatment tank; and at least 50% (by quantity) of the entirety of the activator has a particle size of less than 10 pm. Also provided is an activator therefor. The microorganisms preferably include Bacillus bacteria.
Treatment of municipal wastewater with anaerobic digestion
Low strength wastewater such as municipal sewage is treated using an anaerobic digester. In some examples, a wastewater stream is separated into a solids rich portion and a solids lean portion. The solids lean portion is treated, for example to remove nitrogen. The solids rich portion is treated in an anaerobic digester, preferably with influent or recuperative thickening. In another example, the wastewater stream is fed to an anaerobic digester and solid-liquid separation stages downstream of the digester return active bacteria and undigested organics to the digester. Both cases may use a process train comprising treatment in an anoxic tank followed by a nitritation tank with a portion of the effluent from the nitritation tank recirculated to the anoxic tank to provide nitritation and denitritation.
Treatment of municipal wastewater with anaerobic digestion
Low strength wastewater such as municipal sewage is treated using an anaerobic digester. In some examples, a wastewater stream is separated into a solids rich portion and a solids lean portion. The solids lean portion is treated, for example to remove nitrogen. The solids rich portion is treated in an anaerobic digester, preferably with influent or recuperative thickening. In another example, the wastewater stream is fed to an anaerobic digester and solid-liquid separation stages downstream of the digester return active bacteria and undigested organics to the digester. Both cases may use a process train comprising treatment in an anoxic tank followed by a nitritation tank with a portion of the effluent from the nitritation tank recirculated to the anoxic tank to provide nitritation and denitritation.
Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
Fusion proteins containing a targeting sequence, an exosporium protein, or an exosporium protein fragment that targets the fusion protein to the exosporium of a Bacillus cereus family member are provided. Recombinant Bacillus cereus family members expressing such fusion proteins are also provided. Genetically inactivated Bacillus cereus family members and recombinant Bacillus cereus family members that overexpress exosporium proteins are also provided. Seeds coated with the recombinant Bacillus cereus family members and methods for using the recombinant Bacillus cereus family members (e.g., for stimulating plant growth) are also provided. Various modifications of the recombinant Bacillus cereus family members that express the fusion proteins are further provided. Fusion proteins comprising a spore coat protein and a protein or peptide of interest, recombinant bacteria that express such fusion proteins, seeds coated with such recombinant bacteria, and methods for using such recombinant bacteria (e.g., for stimulating plant growth) are also provided.
COMPOSITIONS AND METHODS FOR TREATING CONTAMINATED WATER
A recombinant Moringa oleifera coagulant protein (MO) produced and secreted by Bacillus has coagulation/flocculation activity. The MO protein and the Bacillus host cells expressing the MO protein can be used in compositions and methods for treating contaminated water, such as drinking water or waste water. The MO protein can coagulate or flocculate suspended solid impurities in the water, which can then be removed.
Treatment of animal and poultry waste to reduce odor
Animal and poultry solid waste material are treated with a preferred lactobacillus organism, preferably plant derived, in a liquid medium, preferably non-chlorinated water for time sufficient to reduce odor a significant amount.
NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROPATHOGENIC E. COLI
The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.
NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROPATHOGENIC E. COLI
The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.